Effectiveness and Safety as Well as Adherence to the S3 Guidelines for the Treatment of Prostate Cancer in the Treatment of Patients of Patients With Firmagon

Trial Profile

Effectiveness and Safety as Well as Adherence to the S3 Guidelines for the Treatment of Prostate Cancer in the Treatment of Patients of Patients With Firmagon

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Degarelix (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top